Condition
Chemotherapy-induced Neuropathy
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Active Not Recruiting1
Unknown1
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04920097Not ApplicableActive Not RecruitingPrimary
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy
NCT06749210Phase 2Recruiting
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
NCT03156595Not ApplicableUnknownPrimary
Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies
NCT01557608Not ApplicableCompletedPrimary
Characterization and Treatment of Chemotherapy Neuropathy
Showing all 4 trials